Ashwagandha and menopause symptoms. Science confirms what Ayurveda has known for centuries

When it comes to ashwagandha and menopause, science is now catching up with the clinic. In January 2026, research published in Frontiers in Reproductive Health confirmed what Ayurvedic medicine has been prescribing for over two thousand years: ashwagandha (Withania somnifera) significantly reduces symptoms associated with menopause, with a safety profile that makes it a valid option for many women who cannot, or choose not to, use hormone replacement therapy. This is the kind of study that changes conversations.

The study that changes the conversation

Until recently, clinical evidence on ashwagandha and menopause rested on partial studies, traditional use data and subjective outcomes. The foundation was solid, but it was not a controlled trial. Now it is. The study is prospective, randomized, double-blind and placebo-controlled. The gold standard, the same standard required of a drug before approval.

What they measured and what they found

Participants received standardized ashwagandha root extract over the trial period. Researchers measured classic menopausal symptoms: hot flushes, insomnia, anxiety, fatigue, mood changes and blood hormonal markers. Results showed statistically significant improvements in hormonal balance, overall vitality and reduction in stress and fatigue. No relevant side effects. No clotting risk or breast tenderness, two of the main reasons women discontinue HRT.

Why it works: the adaptogenic mechanism

Ashwagandha acts on the HPA axis, the hypothalamic-pituitary-adrenal system, which regulates the stress response and cortisol production. In perimenopause, that axis is already under pressure: the decline in oestrogen directly affects nervous system regulation, raising baseline cortisol and amplifying symptoms such as insomnia, hot flushes and anxiety. Ashwagandha does not add hormones. It regulates the system that processes stress. And in a phase where the body is managing a major hormonal transition, that makes a real, measurable difference.

Ashwagandha and menopause: what Ayurveda already knew

In Ayurvedic medicine, ashwagandha belongs to the rasayana group, the rejuvenating adaptogens par excellence. For centuries it has been prescribed specifically for women's life transitions: postpartum, menopause, periods of extreme exhaustion.

Ayurveda understands menopause as a phase of Vata dosha aggravation: the nervous system becomes more sensitive, sleep more fragile, skin drier, the mind more scattered. The goal is not to suppress symptoms, it is to support the body in navigating that transition without losing its fundamental balance.

The Ayurvedic clinical perspective

From an Ayurvedic clinical standpoint, the profile of the woman in perimenopause follows a recognisable pattern: a nervous system overactivated for years, demanding work, mental load, fragmented sleep, converging with a hormonal transition that amplifies that accumulated tension. Clinical observation is consistent with what this study measures: when the stress axis is supported with adaptogens such as ashwagandha, menopausal symptoms moderate. Not because the process is masked, but because the body has more resources to move through it. This sits inside the wider picture of how menopause and Ayurveda work stage by stage.

What this means

A clinical trial of this standard does not close the debate, it opens it in a more informed way. What it tells us is that there are evidence-based tools outside the conventional protocol, and that women deserve to know about them and to decide with full information. Ashwagandha is not magic. It is phytomedicine with centuries of clinical use and, since 2026, with controlled trials to support it. The question is no longer whether it works. The question is whether your protocol includes it.

Sources: Frontiers in Reproductive Health, January 2026 — DOI: 10.3389/frph.2025.1647721, on ashwagandha for menopausal symptoms. Corroborated by Gopal S. et al., Journal of Obstetrics and Gynaecology Research, 2021 — DOI: 10.1111/jog.15030, a randomised, double-blind, placebo-controlled trial of ashwagandha in perimenopause (retrieved via PubMed). This article is for informational purposes and does not replace consultation with a healthcare professional.